7.3473

1.45% -0.1227

Sight Sciences Inc (SGHT)

Overview News Price History Option Chain Financials Why SGHT Down? Discussions Forecast

Sight Sciences Inc stock is traded at $7.3473, with a volume of 21,657. It is down -1.45% in the last 24 hours and down -8.55% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Previous Close:

$7.47

Open:

$7.46

24h Volume:

21,657

Relative Volume:

0.09

Market Cap:

$388.87M

Revenue:

$81.06M

Net Income/Loss:

$-55.55M

P/E Ratio:

-6.445

EPS:

-1.14

Net Cash Flow:

$-47.98M

1W Performance:

-7.17%

1M Performance:

-8.55%

6M Performance:

+111.84%

1Y Performance:

+122.40%

1-Day Range:

$7.26

$7.47

1-Week Range:

$7.26

$8.19

52-Week Range:

$2.03

$9.2362

Sight Sciences Inc Stock (SGHT) Company Profile

Name

Sight Sciences Inc

Sector

Healthcare (1119)

Industry

Medical Devices (141)

Phone

(415) 889-0550

Address

4040 CAMPBELL AVE,, MENLO PARK

Employee

216

Twitter

Next Earnings Date

2025-03-05

Latest SEC Filings

SGHT's Discussions on Twitter

Compare SGHT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGHT Sight Sciences Inc	7.355	394.95M	81.06M	-55.55M	-47.98M	-1.14
ABT Abbott Laboratories	127.00	222.19B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	98.48	144.97B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	365.09	140.12B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	100.67	128.60B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	84.86	49.82B	5.88B	1.34B	799.60M	2.3489

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-26	Upgrade	Piper Sandler	Neutral → Overweight
Aug-08-25	Upgrade	Lake Street	Hold → Buy
Dec-06-24	Initiated	UBS	Buy
Nov-04-24	Downgrade	Lake Street	Buy → Hold
Aug-21-24	Initiated	Lake Street	Buy
Sep-12-23	Downgrade	BofA Securities	Neutral → Underperform
Sep-12-23	Downgrade	Piper Sandler	Overweight → Neutral
Sep-12-23	Downgrade	William Blair	Outperform → Mkt Perform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-10-23	Downgrade	Citigroup	Buy → Neutral
Jan-06-23	Upgrade	Stifel	Hold → Buy
Oct-04-22	Initiated	Needham	Hold
Jul-26-22	Initiated	Stifel	Hold
Feb-03-22	Initiated	William Blair	Outperform
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Sight Sciences Inc Stock (SGHT) Latest News

Jan 06, 2026

Rodberg, Sight Sciences CFO, sells $38,890 in SGHT stock By Investing.com - Investing.com South Africa

Jan 06, 2026

Sight Sciences (SGHT) CTO Badawi sells $73k in stock By Investing.com - Investing.com Canada

Jan 06, 2026

Sight Sciences (SGHT): chief legal officer Hayden sells $86k in stock By Investing.com - Investing.com South Africa

Jan 06, 2026

Sight Sciences (SGHT): chief legal officer Hayden sells $86k in stock - Investing.com India

Jan 06, 2026

What analysts say about Sight Sciences Inc stockDividend Aristocrats List & Affordable Trading Strategies - earlytimes.in

Jan 06, 2026

Jan 05, 2026

Piper Sandler upgrades Sight Sciences stock rating to Overweight By Investing.com - Investing.com Nigeria

Jan 05, 2026

Published on: 2026-01-06 08:42:12 - earlytimes.in

Jan 05, 2026

What drives Sight Sciences Inc stock priceTechnical Analysis Insights & Capital Growth Strategies - earlytimes.in

Jan 05, 2026

Piper Sandler upgrades Sight Sciences on strong business prospects - TradingView — Track All Markets

Jan 05, 2026

Jan 02, 2026

Sight sciences CTO David Badawi sells $15,081 in stock - MSN

Jan 02, 2026

Dec 31, 2025

The Truth About Sight Sciences Inc (SGHT): Silent Wall Street Underdog Or Total Flop? - AD HOC NEWS

Dec 31, 2025

Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge (NASDAQ:SGHT) - Seeking Alpha

Dec 31, 2025

Piper Sandler upgrades Sight Sciences stock rating to Overweight - Investing.com

Dec 31, 2025

Dec 27, 2025

Sight Sciences (SGHT) price target increased by 22.34% to 8.01 - MSN

Dec 27, 2025

Dec 25, 2025

Institutions profited after Sight Sciences, Inc.'s (NASDAQ:SGHT) market cap rose US$48m last week but individual investors profited the most - simplywall.st

Dec 25, 2025

Dec 23, 2025

Sight Sciences price target raised to $12 from $7 at UBS - Yahoo Finance

Dec 23, 2025

UBS Maintains Sight Sciences (SGHT) Buy Recommendation - Nasdaq

Dec 23, 2025

Dec 22, 2025

SGHT’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com

Dec 22, 2025

Dec 21, 2025

What makes Sight Sciences, Inc. (SGHT) a strong momentum stock: Buy now? - MSN

Dec 21, 2025

Sight Sciences (SGHT) Price Target Increased by 22.34% to 8.01 - Nasdaq

Dec 21, 2025

Dec 20, 2025

Will Sight Sciences Inc. stock benefit from sector rotationTrade Volume Summary & Low Drawdown Momentum Trade Ideas - Улправда

Dec 20, 2025

How resilient is Sight Sciences Inc. stock in market downturnsPortfolio Return Report & Reliable Entry Point Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Will Sight Sciences Inc. stock outperform Dow Jones index2025 Top Decliners & AI Based Buy/Sell Signal Reports - Улправда

Dec 19, 2025